Trial
NCT00909363
Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Weill Medical College of Cornell University
Collaborators
Novartis Pharmaceuticals
Condition
Wiskott-Aldrich Syndrome
Intervention
Promacta
Why stopped
retirement of PI
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-03-18